| scholarly article | Q13442814 |
| P50 | author | Zhong Huang | Q47409724 |
| Xiaohua Ye | Q89417653 | ||
| P2093 | author name string | Xiaoli Wang | |
| Chao Zhang | |||
| Yingyi Zhang | |||
| Xia Jin | |||
| Qingwei Liu | |||
| Tan Chen | |||
| Zhiqiang Ku | |||
| Wenlong Dai | |||
| P2860 | cites work | Dengue vaccines: progress and challenges | Q37868122 |
| Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis | Q38081967 | ||
| Challenges for the formulation of a universal vaccine against dengue. | Q38121757 | ||
| Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus | Q39538904 | ||
| Proposal for a unified norovirus nomenclature and genotyping | Q41513884 | ||
| Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults | Q41743964 | ||
| A DNA replicon system for rapid high-level production of virus-like particles in plants | Q42200961 | ||
| A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice | Q42211021 | ||
| A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses | Q42222745 | ||
| Binding of recombinant norovirus like particle to histo-blood group antigen on cells in the lumen of pig duodenum | Q43222360 | ||
| Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. | Q44079611 | ||
| Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. | Q44201038 | ||
| A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge | Q45354931 | ||
| Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge | Q45396589 | ||
| Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers | Q45711236 | ||
| Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins. | Q46973953 | ||
| Norovirus classification and proposed strain nomenclature | Q48706045 | ||
| Immunogenetic mechanisms driving norovirus GII.4 antigenic variation | Q24810360 | ||
| Human susceptibility and resistance to Norwalk virus infection | Q28190653 | ||
| Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002. | Q30409563 | ||
| The state of norovirus vaccines | Q33678125 | ||
| Serological Correlate of Protection against Norovirus‐Induced Gastroenteritis | Q34153875 | ||
| Viral gastroenteritis in children | Q34155941 | ||
| Susceptibility to winter vomiting disease: a sweet matter | Q34227237 | ||
| Enterovirus-71 virus-like particles induce the activation and maturation of human monocyte-derived dendritic cells through TLR4 signaling | Q34435050 | ||
| Enteric bacteria promote human and mouse norovirus infection of B cells | Q34446799 | ||
| Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps | Q34603692 | ||
| An overview of the evolution of enterovirus 71 and its clinical and public health significance | Q34635602 | ||
| Norovirus P particle efficiently elicits innate, humoral and cellular immunity | Q34702360 | ||
| Systematic literature review of role of noroviruses in sporadic gastroenteritis | Q34804404 | ||
| Norovirus-host interaction: multi-selections by human histo-blood group antigens | Q35146233 | ||
| Construction and characterization of an infectious clone of coxsackievirus A16. | Q35768977 | ||
| Norovirus vaccine development: next steps | Q37133116 | ||
| Norovirus vaccine against experimental human Norwalk Virus illness | Q37144052 | ||
| Evolutionary dynamics of GII.4 noroviruses over a 34-year period. | Q37410684 | ||
| Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013. | Q37546555 | ||
| Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms | Q37547757 | ||
| Human enterovirus 71 and hand, foot and mouth disease. | Q37670343 | ||
| Development of enterovirus 71 vaccines. | Q37682898 | ||
| Diseases caused by enterovirus 71 infection | Q37684695 | ||
| EV71: an emerging infectious disease vaccine target in the Far East? | Q37715371 | ||
| Virology, epidemiology, pathogenesis, and control of enterovirus 71. | Q37801742 | ||
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | norovirus | Q1142751 |
| P304 | page(s) | 5779-5785 | |
| P577 | publication date | 2015-09-27 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice | |
| P478 | volume | 33 |
| Q90491213 | Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus |
| Q47557837 | Development of a Surrogate Neutralization Assay for Norovirus Vaccine Evaluation at the Cellular Level |
| Q33703664 | Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder |
| Q40283651 | Molecular analysis of norovirus in specimens from children enrolled in a 1982-1986 study in Belém, Brazil: A community-based longitudinal study |
| Q40261280 | Molecular analysis of norovirus in specimens from children enrolled in a 1982-1986 study in Belém, Brazil: A community-based longitudinal study. |
| Q98177689 | Norovirus Vaccine: Priorities for Future Research and Development |
| Q38698429 | Norovirus vaccines under development |
| Q91726510 | Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection |
| Q57163766 | Progress on norovirus vaccine research: public health considerations and future directions |
| Q38795763 | Status of vaccine research and development for norovirus |
| Q40044140 | Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future |
Search more.